{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:36:27Z","timestamp":1794472587027,"version":"4.9.1"},"reference-count":131,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Acute myocardial infarction (MI) represents one of the most common hospital encounters, with significant short-term and long-term morbidity and mortality, and frequently occurs in patients with chronic kidney disease (CKD). Cardiac troponin is an exquisitely sensitive biomarker for myocardial injury and plays an essential role in the diagnosis, risk-stratification, and management of MI. In 2017, the United States Food and Drug Administration approved Roche Diagnostics\u2019 5th generation high-sensitivity cardiac troponin (hs-cTn) for clinical use. Whilst the improved analytical sensitivity of these new high-sensitivity troponin assays facilitate early diagnosis of MI, it also frequently identifies troponin elevations above the conventional reference threshold in the context of non-coronary conditions such as renal dysfunction, and can represent a major diagnostic challenge to clinicians. Furthermore, the optimal management strategy of patients with troponin elevation and high comorbidity burden, a common issue in patients with CKD, remains undefined. In recent years, there has been substantial research and progress undertaken in this rapidly evolving area. In this review, we aim to provide clinicians with an overview of hs-cTn in the setting of CKD as well as an update on its application and the particular considerations involved in the management of myocardial infarction, stable coronary artery disease and myocardial injury in this high risk population.<\/jats:p>","DOI":"10.31083\/j.rcm.2020.02.17","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T07:12:31Z","timestamp":1593587551000},"source":"Crossref","is-referenced-by-count":38,"title":["High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond"],"prefix":"10.31083","volume":"21","author":[{"given":"Anthony (Ming-yu)","family":"Chuang","sequence":"first","affiliation":[{"name":"School of Medicine, Flinders University of South Australia, Adelaide 5042, Australia"},{"name":"Department of Cardiovascular Medicine, Southern Adelaide Local Health Network, Adelaide 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mau T","family":"Nguyen","sequence":"first","affiliation":[{"name":"Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon-Man","family":"Kung","sequence":"first","affiliation":[{"name":"Department of Exercise and Health Promotion, College of Education, Chinese Culture University, Taipei 11114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Lehman","sequence":"first","affiliation":[{"name":"School of Medicine, Flinders University of South Australia, Adelaide 5042, Australia"},{"name":"Department of Cardiovascular Medicine, Southern Adelaide Local Health Network, Adelaide 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek P","family":"Chew","sequence":"first","affiliation":[{"name":"School of Medicine, Flinders University of South Australia, Adelaide 5042, Australia"},{"name":"Department of Cardiovascular Medicine, Southern Adelaide Local Health Network, Adelaide 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Adamson, P. D., Hunter, A., Shah, A., McAllister, D., Pawade, T., Williams, M., Van Beek, E., Mills, N. and Newby, D. (2017) High-sensitivity cardiac troponin I and the diagnosis of obstructive coronary artery disease in patients with suspected stable angina. Journal of the American College of Cardiology 69, 19.","DOI":"10.1016\/S0735-1097(17)33408-3"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Al-Lamee, R., Thompson, D., Dehbi, H. M., Sen, S., Tang, K. and Davies, J. (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomized controlled trial. Journal of Vascular Surgery 67, 673.","DOI":"10.1016\/j.jvs.2017.11.046"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Alpert, J. S., Thygesen, K. A., White, H. D. and Jaffe, A. S. (2014) Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. The American Journal of Medicine 127, 105-108. 24462011https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24462011","DOI":"10.1016\/j.amjmed.2013.09.031"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alpert, J. S., Thygesen, K., Antman, E. and Bassand, J. P. (2000) Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 36, 959-969.","DOI":"10.1016\/S0735-1097(00)00804-4"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., Levine, G. N., Liebson, P. R., Mukherjee, D., Peterson, E. D., Sabatine, M. S., Smalling, R. W. and Zieman, S. J. (2014) 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology 64, e139-e228.","DOI":"10.1016\/j.jacc.2014.09.017"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Apple, F. S., Ler, R. and Murakami, M. M. (2012) Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clinical Chemistry 58, 1574-1581.","DOI":"10.1373\/clinchem.2012.192716"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Apple, F. S., Sandoval, Y., Jaffe, A. S. and Ordonez-Llanos, J. (2017) Cardiac troponin assays: Guide to understanding analytical characteristics and their impact on clinical care. Clinical Chemistry 63, 73-81.","DOI":"10.1373\/clinchem.2016.255109"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Arroyo-Espliguero, R., Avanzas, P., Cos\u0131\u0301n-Sales, J., Aldama, G., Pizzi, C. and Kaski, J. C. (2004) C-reactive protein elevation and disease activity in patients with coronary artery disease. ACC Current Journal Review 13, 11-12.","DOI":"10.1016\/j.accreview.2004.06.018"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Bansal, N., Katz, R., Robinson-Cohen, C., Odden, M. C., Dalrymple, L., Shlipak, M. G., Sarnak, M. J., Siscovick, D. S., Zelnick, L., Psaty, B. M., Kestenbaum, B., Correa, A., Afkarian, M., Young, B. and de Boer, I. H. (2017) Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies. JAMA Cardiology 2, 314-318. 28002548https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28002548","DOI":"10.1001\/jamacardio.2016.4652"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Jordan, L. C., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., Lackland, D. T., Lewis, T. T., Lichtman, J. H., Longenecker, C. T., Loop, M. S., Lutsey, P. L., Martin, S. S., Matsushita, K., Moran, A. E., Mussolino, M. E., O'Flaherty, M., Pandey, A., Perak, A. M., Rosamond, W. D., Roth, G. A., Sampson, U. K. A., Satou, G. M., Schroeder, E. B., Shah, S. H., Spartano, N. L., Stokes, A., Tirschwell, D. L., Tsao, C. W., Turakhia, M. P., VanWagner, L. B., Wilkins, J. T., Wong, S. S. and Virani, S. S. (2019) Heart disease and stroke statistics-2019 Update: A report from the American Heart Association. Circulation 139,","DOI":"10.1161\/CIR.0000000000000659"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J. and Weintraub, W. S. (2007) Optimal medical therapy with or without PCI for stable coronary disease. New England Journal of Medicine 356, 1503-1516.","DOI":"10.1056\/NEJMoa070829"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Boland, J. E. and Muller, D. W. M. (2019) Interventional Cardiology and Cardiac Catheterisation, 2nd edn. Boca Raton FL: CRC Press","DOI":"10.1201\/9781351060356"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bundy, J. D., Chen, J., Yang, W., Budoff, M., Go, A. S., Grunwald, J. E., Kallem, R. R., Post, W. S., Reilly, M. P., Ricardo, A. C., Rosas, S. E., Zhang, X., He, J. and Investigators, C. S. (2018) Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study. Atherosclerosis 271, 53-60.","DOI":"10.1016\/j.atherosclerosis.2018.02.009"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Burton, J. O., Jefferies, H. J., Selby, N. M. and McIntyre, C. W. (2009) Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clinical journal of the American Society of Nephrology: CJASN 4, 1925-1931.","DOI":"10.2215\/CJN.04470709"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Cardinaels, E. P. M., Altintas, S., Versteylen, M. O., Joosen, I. A., Jellema, L.-J. C., Wildberger, J. E., Das, M., Crijns, H. J., Bekers, O., van Dieijen-Visser, M. P., Kietselaer, B. L. and Mingels, A. M. A. (2016) High-sensitivity cardiac troponin concentrations in patients with chest discomfort: Is it the heart or the kidneys as well? PloS one 11, e0153300-e0153300.","DOI":"10.1371\/journal.pone.0153300"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Charytan, D. M., Sabatine, M. S., Pedersen, T. R., Im, K., Park, J.-G., Pineda, A. L., Wasserman, S. M., Deedwania, P., Olsson, A. G., Sever, P. S., Keech, A. C. and Giugliano, R. P. (2019) Efficacy and safety of evolocumab in chronic kidney disease in the FOURIER trial. Journal of the American College of Cardiology 73, 2961-2970.","DOI":"10.1016\/j.jacc.2019.03.513"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Charytan, D. M., Wallentin, L., Lagerqvist, B., Spacek, R., De Winter, R. J., Stern, N. M., Braunwald, E., Cannon, C. P. and Choudhry, N. K. (2009) Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clinical Journal of the American Society of Nephrology: CJASN 4, 1032-1043.","DOI":"10.2215\/CJN.05551008"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Chen, S., Huang, C., Wu, B., Lian, X., Mei, X. and Wan, J. (2013) Cardiac troponin I in non- acute coronary syndrome patients with chronic kidney disease. PloS One 8, e82752-e82752.","DOI":"10.1371\/journal.pone.0082752"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chesnaye, N., Szummer, K., Barany, P., Heimburger, O., Magin, H., Uhlin, F., Dekker, F. W., Wanner, C., Jager, K. and Evans, M. (2019) FP411 the association between renal function and troponin T over time in stable CKD patients. Nephrology Dialysis Transplantation 34","DOI":"10.1093\/ndt\/gfz106.FP411"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Chew, D. P., Briffa, T. G., Alhammad, N. J., Horsfall, M., Zhou, J., Lou, P. W., Coates, P., Scott, I., Brieger, D., Quinn, S. J. and French, J. (2014) High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality. European Heart Journal: Acute Cardiovascular Care 4, 419-428. 25505224https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25505224","DOI":"10.1177\/2048872614564083"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Chew, D. P., Lambrakis, K., Blyth, A., Seshadri, A., Edmonds, M. J. R., Briffa, T., Cullen, L. A., Quinn, S., Karnon, J., Chuang, A., Nelson, A. J., Wright, D., Horsfall, M., Morton, E., French, J. K. and Papendick, C. (2019) A randomized trial of a 1-hour Troponin T protocol in suspected acute coronary syndromes. Circulation 140, 1543-1556.","DOI":"10.1161\/CIRCULATIONAHA.119.042891"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M. and Aylward, P. E. G. (2016) National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart, Lung and Circulation 25, 895-951.","DOI":"10.1016\/j.hlc.2016.06.789"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Chuang, A., Hancock, D. G., Halabi, A., Horsfall, M., Vaile, J., De Pasquale, C., Sinhal, A., Jones, D., Brogan, R. and Chew, D. P. (2018) Invasive management of acute coronary syndrome: Interaction with competing risks. International Journal of Cardiology 269, 13-18.","DOI":"10.1016\/j.ijcard.2018.07.078"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Chuang, A., Hancock, D. G., Horsfall, M., Alhammad, N. J., Zhou, J., Cullen, L., French, J. and Chew, D. P. (2016) The predictive value of high sensitivity-troponin velocity within the first 6h of presentation for cardiac outcomes regardless of acute coronary syndrome diagnosis. International Journal of Cardiology 204, 106-111.","DOI":"10.1016\/j.ijcard.2015.11.132"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Culleton, B. F., Larson, M. G., Wilson, P. W. F., Evans, J. C., Parfrey, P. S. and Levy, D. (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney International 56, 2214-2219.","DOI":"10.1046\/j.1523-1755.1999.00773.x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Damman, P., Clayton, T., Wallentin, L., Lagerqvist, B., Fox, K. A. A., Hirsch, A., Windhausen, F., Swahn, E., Pocock, S. J., Tijssen, J. G. P. and de Winter, R. J. (2011) Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials. Heart 98, 207-213.","DOI":"10.1136\/heartjnl-2011-300453"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"deFilippi, C. R. and Herzog, C. A. (2017) Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clinical Chemistry 63, 59-65. 27811207https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27811207","DOI":"10.1373\/clinchem.2016.254748"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Everett, B. M., Brooks, M. M., Vlachos, H. E. A., Chaitman, B. R., Frye, R. L., Bhatt, D. L. and Group, B. D. S. (2015) Troponin and cardiac events in stable ischemic heart disease and diabetes. The New England Journal of medicine 373, 610-620.","DOI":"10.1056\/NEJMoa1415921"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Feres, F. (2013) Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial JAMA 310, 2510-2522. 24177257https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24177257","DOI":"10.1001\/jama.2013.282183"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Flores-Sol\u00eds, L. M. and Hern\u00e1ndez-Dom\u00ednguez, J. L. (2014) Cardiac troponin I in patients with chronic kidney disease stage 3 to 5 in conditions other than acute coronary syndrome. Clinical Laboratory 60, 281-290.","DOI":"10.7754\/Clin.Lab.2013.121103"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Fox, K. A. A., Clayton, T. C., Damman, P., Pocock, S. J., de Winter, R. J., Tijssen, J. G. P., Lagerqvist, B. and Wallentin, L. (2010) Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome. Journal of the American College of Cardiology 55, 2435-2445.","DOI":"10.1016\/j.jacc.2010.03.007"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Frid\u00e9n, V., Starnberg, K., Muslimovic, A., Ricksten, S.-E., Bjurman, C., Forsgard, N., Wickman, A. and Hammarsten, O. (2017) Clearance of cardiac troponin T with and without kidney function. Clinical Biochemistry 50, 468-474.","DOI":"10.1016\/j.clinbiochem.2017.02.007"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Furtado, R. H. M., Bonaca, M. P., Raz, I., Zelniker, T. A., Mosenzon, O., Cahn, A., Kuder, J., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Nicolau, J. C., Gause-Nilsson, I. A. M., Fredriksson, M., Langkilde, A. M., Sabatine, M. S. and Wiviott, S. D. (2019) Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction. Circulation 139, 2516-2527.","DOI":"10.1161\/CIRCULATIONAHA.119.039996"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ganguly, P. and Alam, S. F. (2015) Role of homocysteine in the development of cardiovascular disease. Nutrition Journal 14, 6-6.","DOI":"10.1186\/1475-2891-14-6"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Garg, P., Morris, P., Fazlanie, A. L., Vijayan, S., Dancso, B., Dastidar, A. G., Plein, S., Mueller, C. and Haaf, P. (2017) Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Internal and Emergency Medicine 12, 147-155.","DOI":"10.1007\/s11739-017-1612-1"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Gerhardt, W., Katus, H., Ravkilde, J., Hamm, C., J\u00f8rgensen, P. J., Peheim, E., Ljungdahl, L. and L\u00f6fdahl, P. (1991) S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clinical Chemistry 37, 1405-1411. 1868602https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1868602","DOI":"10.1093\/clinchem\/37.8.1405"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S. and Katus, H. A. (2010) Analytical validation of a high-sensitivity cardiac troponin T assay. Clinical Chemistry 56, 254-261. 19959623https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19959623","DOI":"10.1373\/clinchem.2009.132654"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. and Hsu, C. Y. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. ACC Current Journal Review 13, 13.","DOI":"10.1016\/j.accreview.2004.11.016"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Gualandro, D. M., Campos, C. A., Calderaro, D., Yu, P. C., Marques, A. C., Pastana, A. F., Lemos, P. A. and Caramelli, B. (2012) Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: Frequent and dangerous. Atherosclerosis 222, 191-195. 22410124https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22410124","DOI":"10.1016\/j.atherosclerosis.2012.02.021"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Gunsolus, I., Sandoval, Y., Smith, S. W., Sexter, A., Schulz, K., Herzog, C. A. and Apple, F. S. (2018) Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I. Journal of the American Society of Nephrology: JASN 29, 636-643. 29079658https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29079658","DOI":"10.1681\/ASN.2017030341"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Hahn, J.-Y., Song, Y. B., Oh, J.-H., Chun, W. J., Park, Y. H., Jang, W. J., Im, E.-S., Jeong, J.-O., Cho, B. R., Oh, S. K., Yun, K. H., Cho, D.-K., Lee, J.-Y., Koh, Y.-Y., Bae, J.-W., Choi, J. W., Lee, W. S., Yoon, H. J., Lee, S. U., Cho, J. H., Choi, W. G., Rha, S.-W., Lee, J. M., Park, T. K., Yang, J. H., Choi, J.-H., Choi, S.-H., Lee, S. H. and Gwon, H.-C. (2019) Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: The SMART-CHOICE randomized clinical trial. JAMA 321, 2428-2437.","DOI":"10.1001\/jama.2019.8146"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Henderson, R. A., Jarvis, C., Clayton, T., Pocock, S. J. and Fox, K. A. A. (2015) 10-year mortality outcome of a routine invasive strategy versus a selective invasive strategy in non-ST-segment elevation acute coronary syndrome. Journal of the American College of Cardiology 66, 511-520.","DOI":"10.1016\/j.jacc.2015.05.051"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Herzog, C. A., Littrell, K., Arko, C., Frederick, P. D. and Blaney, M. (2007) Clinical characteristics of dialysis patients with acute myocardial infarction in the united states. Circulation 116, 1465-1472.","DOI":"10.1161\/CIRCULATIONAHA.107.696765"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A. G., Zannad, F., Norby, G. E., Fellstr\u00f6m, B. C. and group, A. s. (2011) Rosuvastatin in diabetic hemodialysis patients. Journal of the American Society of Nephrology: JASN 22, 1335-1341. 21566054https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21566054","DOI":"10.1681\/ASN.2010090987"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"House, A. A., Wanner, C., Sarnak, M. J., Pi\u00f1a, I. L., McIntyre, C. W., Komenda, P., Kasiske, B. L., Deswal, A., deFilippi, C. R., Cleland, J. G. F., Anker, S. D., Herzog, C. A., Cheung, M., Wheeler, D. C., Winkelmayer, W. C. and McCullough, P. A. (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International 95, 1304-1317.","DOI":"10.1016\/j.kint.2019.02.022"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Hruska, K., Mathew, S., Lund, R., Fang, Y. and Sugatani, T. (2011) Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney International Supplement 79, S9-S13.","DOI":"10.1038\/ki.2011.24"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Ib\u00e1nez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P. and Widimsk\u00fd, P. (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 70, 1082.","DOI":"10.1016\/j.rec.2017.11.010"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Iwagami, M., Caplin, B., Smeeth, L., Tomlinson, L. A. and Nitsch, D. (2018) Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data. The British Journal of General Practice: the Journal of the Royal College of General Practitioners 68, e512-e523.","DOI":"10.3399\/bjgp18X697973"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Januzzi, J. L., Butler, J., Jarolim, P., Sattar, N., Vijapurkar, U., Desai, M. and Davies, M. J. (2017) Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. Journal of the American College of Cardiology 70, 704-712.","DOI":"10.1016\/j.jacc.2017.06.016"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Januzzi, J. L., Jr., Suchindran, S., Coles, A., Ferencik, M., Patel, M. R., Hoffmann, U., Ginsburg, G. S., Douglas, P. S. and Investigators, P. (2019a) High-sensitivity troponin I and coronary computed tomography in symptomatic outpatients with suspected CAD: Insights from the PROMISE trial. JACC Cardiovascular Imaging 12, 1047-1055.","DOI":"10.1016\/j.jcmg.2018.01.021"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Januzzi, J. L., Mahler, S. A., Christenson, R. H., Rymer, J., Newby, L. K., Body, R., Morrow, D. A. and Jaffe, A. S. (2019b) Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing. Journal of the American College of Cardiology 73, 1059-1077.","DOI":"10.1016\/j.jacc.2018.12.046"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Janzon, M., Henriksson, M., Hasvold, P., Hjelm, H., Thuresson, M. and Jernberg, T. (2016) Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study. European Heart Journal - Quality of Care and Clinical Outcomes 2, 291-298. 29474723https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29474723","DOI":"10.1093\/ehjqcco\/qcw019"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Jardine, M. J., Mahaffey, K. W., Neal, B., Agarwal, R., Bakris, G. L., Brenner, B. M., Bull, S., Cannon, C. P., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., Levin, A., Pollock, C., Wheeler, D. C., Xie, J., Zhang, H., Zinman, B., Desai, M., Perkovic, V. and investigators, C. s. (2017) The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics. American Journal of Nephrology 46, 462-472. 29253846https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29253846","DOI":"10.1159\/000484633"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Jolly, S. S., James, S., D\u017eav\u00edk, V., Cairns, J. A., Mahmoud, K. D., Zijlstra, F., Yusuf, S., Olivecrona, G. K., Renlund, H., Gao, P., Lagerqvist, B., Alazzoni, A., Kedev, S., Stankovic, G., Meeks, B. and Fr\u00f8bert, O. (2017) Thrombus aspiration in ST-segment-elevation myocardial infarction. Circulation 135, 143-152. 27941066https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27941066","DOI":"10.1161\/CIRCULATIONAHA.116.025371"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Kaysen, G. A. (2009a) Lipid and lipoprotein metabolism in chronic kidney disease. Journal of Renal Nutrition 19, 73-77.","DOI":"10.1053\/j.jrn.2008.10.011"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Kaysen, G. A. (2009b) New insights into lipid metabolism in chronic kidney disease: What are the practical implications? Blood Purification 27, 86-91.","DOI":"10.1159\/000167015"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Kendrick, J. and Chonchol, M. B. (2008) Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nature Clinical Practice Nephrology 4, 672-681. 18825155https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18825155","DOI":"10.1038\/ncpneph0954"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Kereiakes, D. J., Yeh, R. W., Massaro, J. M., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Gershlick, A. H., Darius, H., Meredith, I. T., Ormiston, J., Tanguay, J. F., Windecker, S., Garratt, K. N., Kandzari, D. E., Lee, D. P., Simon, D. I., Iancu, A. C., Trebacz, J., Mauri, L. and Dual Antiplatelet Therapy Study, I. (2015) Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA 313, 1113-1121.","DOI":"10.1001\/jama.2015.1671"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J. and Andress, D. L. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. Journal of the American Society of Nephrology: JASN 16, 520-528.","DOI":"10.1681\/ASN.2004070602"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Khwaja, A. (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron 120, c179-c184.","DOI":"10.1159\/000339789"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Kim, B.-K., Hong, M.-K., Shin, D.-H., Nam, C.-M., Kim, J.-S., Ko, Y.-G., Choi, D., Kang, T.-S., Park, B.-E., Kang, W.-C., Lee, S.-H., Yoon, J.-H., Hong, B.-K., Kwon, H.-M. and Jang, Y. (2012) A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). Journal of the American College of Cardiology 60, 1340-1348.","DOI":"10.1016\/j.jacc.2012.06.043"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., Mahfoud, F., Masip, J., Muneretto, C., Valgimigli, M., Achenbach, S. and Bax, J. J. (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal 41, 407-477.","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Kosiborod, M. N., Jhund, P. S., Docherty, K. F., Diez, M., Petrie, M. C., Verma, S., Nicolau, J. C., Merkely, B., Kitakaze, M., DeMets, D. L., Inzucchi, S. E., K\u00f8ber, L., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Lindholm, D., Niklasson, A., Sj\u00f6strand, M., Langkilde, A. M. and McMurray, J. J. V. (2020) Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: Results from the DAPA-HF trial. Circulation 141, 90-99.","DOI":"10.1161\/CIRCULATIONAHA.119.044138"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Lambrakis, K., French, J. K., Scott, I. A., Briffa, T., Brieger, D., Farkouh, M. E., White, H., Chuang, A., Tiver, K., Quinn, S., Kaambwa, B., Horsfall, M., Morton, E. and Chew, D. P. (2019) The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design. American Heart Journal 208, 11-20.","DOI":"10.1016\/j.ahj.2018.09.016"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Lindahl, B., Jernberg, T., Badertscher, P., Boeddinghaus, J., Eggers, K. M., Frick, M., Rubini Gimenez, M., Linder, R., Ljung, L., Martinsson, A., Melki, D., Nestelberger, T., Rentsch, K., Reichlin, T., Sabti, Z., Schubera, M., Svensson, P., Twerenbold, R., Wildi, K. and Mueller, C. (2016) An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay. Heart 103, 125-131.","DOI":"10.1136\/heartjnl-2016-309951"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Manjunath, G., Tighiouart, H., Ibrahim, H., MacLeod, B., Salem, D. N., Griffith, J. L., Coresh, J., Levey, A. S. and Sarnak, M. J. (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Journal of the American College of Cardiology 41, 47-55. 12570944https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12570944","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Martinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., K\u00f8ber, L., Kosiborod, M. N., Ponikowski, P., Sabatine, M. S., DeMets, D. L., Dutkiewicz-Piasecka, M., Bengtsson, O., Sj\u00f6strand, M., Langkilde, A. M., Jhund, P. S. and McMurray, J. J. V. (2020) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age. Circulation 141, 100-111. 31736328https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31736328","DOI":"10.1161\/CIRCULATIONAHA.119.044133"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Matsushita, K., Ballew, S. H., Astor, B. C., Jong, P. E. d., Gansevoort, R. T., Hemmelgarn, B. R., Levey, A. S., Levin, A., Wen, C.-P., Woodward, M. and Coresh, J. (2013) Cohort profile: the chronic kidney disease prognosis consortium. International Journal of Epidemiology 42, 1660-1668.","DOI":"10.1093\/ije\/dys173"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., Coresh, J. and Gansevoort, R. T. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (London, England) 375, 2073-2081.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"McFalls, E. O., Larsen, G., Johnson, G. R., Apple, F. S., Goldman, S., Arai, A., Nallamothu, B. K., Jesse, R., Holmstrom, S. T. and Sinnott, P. L. (2011) Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. The American Journal of Medicine 124, 630-635.","DOI":"10.1016\/j.amjmed.2011.02.024"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., K\u00f8ber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., B\u011blohl\u00e1vek, J., B\u00f6hm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., Desai, A. S., Diez, M., Drozdz, J., Duk\u00e1t, A., Ge, J., Howlett, J. G., Katova, T., Kitakaze, M., Ljungman, C. E. A., Merkely, B., Nicolau, J. C., O'Meara, E., Petrie, M. C., Vinh, P. N., Schou, M., Tereshchenko, S., Verma, S., Held, C., DeMets, D. L., Docherty, K. F., Jhund, P. S., Bengtsson, O., Sj\u00f6strand, M. and Langkilde, A.-M. (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. The New England Journal of Medicine 381, 1995-2008.","DOI":"10.1056\/NEJMoa1911303"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"McRae, A. D., Innes, G., Graham, M., Lang, E., Andruchow, J. E., Yang, H., Ji, Y., Vatanpour, S., Southern, D. A., Wang, D., Seiden-Long, I., DeKoning, L. and Kavsak, P. (2017) Comparative evaluation of 2-hour rapid diagnostic algorithms for acute myocardial infarction using high-sensitivity cardiac troponin T. Canadian Journal of Cardiology 33, 1006-1012.","DOI":"10.1016\/j.cjca.2017.04.010"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Mehran, R., Baber, U., Sharma, S. K., Cohen, D. J., Angiolillo, D. J., Briguori, C., Cha, J. Y., Collier, T., Dangas, G., Dudek, D., D\u017eav\u00edk, V., Escaned, J., Gil, R., Gurbel, P., Hamm, C. W., Henry, T., Huber, K., Kastrati, A., Kaul, U., Kornowski, R., Krucoff, M., Kunadian, V., Marx, S. O., Mehta, S. R., Moliterno, D., Ohman, E. M., Oldroyd, K., Sardella, G., Sartori, S., Shlofmitz, R., Steg, P. G., Weisz, G., Witzenbichler, B., Han, Y.-l., Pocock, S. and Gibson, C. M. (2019) Ticagrelor with or without Aspirin in High-Risk Patients after PCI. New England Journal of Medicine 381, 2032-2042. 31556978https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31556978","DOI":"10.1056\/NEJMoa1908419"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Messow, C. M. and Isles, C. (2017) Meta-analysis of statins in chronic kidney disease: who benefits? QJM: An International Journal of Medicine 110, 493-500.","DOI":"10.1093\/qjmed\/hcx040"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Miller-Hodges, E., Anand, A., Shah, A. S. V., Chapman, A. R., Gallacher, P., Lee, K. K., Farrah, T., Halbesma, N., Blackmur, J. P., Newby, D. E., Mills, N. L. and Dhaun, N. (2018) High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation 137, 425-435.","DOI":"10.1161\/CIRCULATIONAHA.117.030320"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Nakamura, S., Ishibashi-Ueda, H., Niizuma, S., Yoshihara, F., Horio, T. and Kawano, Y. (2009) Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clinical journal of the American Society of Nephrology: CJASN 4, 1892-1900.","DOI":"10.2215\/CJN.04320709"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Nakano, T., Ninomiya, T., Sumiyoshi, S., Fujii, H., Doi, Y., Hirakata, H., Tsuruya, K., Iida, M., Kiyohara, Y. and Sueishi, K. (2010) Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. American Journal of Kidney Diseases 55, 21-30.","DOI":"10.1053\/j.ajkd.2009.06.034"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M. and Matthews, D. R. (2017) Canagliflozin and cardiovascular and renal events in type 2 diabetes. New England Journal of Medicine 377, 644-657.","DOI":"10.1056\/NEJMoa1611925"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Nuhu, F. and Bhandari, S. (2018) Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia. Pharmaceuticals (Basel, Switzerland) 11, 103.","DOI":"10.3390\/ph11040103"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Omland, T., Pfeffer, M. A., Solomon, S. D., de Lemos, J. A., R\u00f8sj\u00f8, H., \u0160altyt\u0117 Benth, J., Maggioni, A., Domanski, M. J., Rouleau, J. L., Sabatine, M. S. and Braunwald, E. (2013) Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. Journal of the American College of Cardiology 61, 1240-1249. 23414791https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23414791","DOI":"10.1016\/j.jacc.2012.12.026"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Owen, R. J., Hiremath, S., Myers, A., Fraser-Hill, M. and Barrett, B. J. (2014) Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Canadian Association of Radiologists Journal 65, 96-105. 24559602https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24559602","DOI":"10.1016\/j.carj.2012.11.002"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Palmer, S. C., Navaneethan, S. D., Craig, J. C., Perkovic, V., Johnson, D. W., Nigwekar, S. U., Hegbrant, J. and Strippoli, G. F. (2014) HMG CoA reductase inhibitors (statins) for kidney transplant recipients. The Cochrane database of systematic reviews CD005019. 19370615https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19370615","DOI":"10.1002\/14651858.CD005019.pub4"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J. and Smith, P. K. (2017a) ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2016 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes. Journal of Nuclear Cardiology 24, 439-463.","DOI":"10.1007\/s12350-017-0780-8"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J. and Smith, P. K. (2017b) ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. Journal of Nuclear Cardiology 24, 1759-1792.","DOI":"10.1007\/s12350-017-0917-9"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Patschan, D., Buschmann, I. and Ritter, O. (2018) Contrast-Induced Nephropathy: Update on the use of crystalloids and pharmacological measures. International Journal of Nephrology 2018, 5727309-5727309.","DOI":"10.1155\/2018\/5727309"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Pfortmueller, C. A., Funk, G.-C., Marti, G., Leichtle, A. B., Fiedler, G. M., Schwarz, C., Exadaktylos, A. K. and Lindner, G. (2013) Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. The American Journal of Cardiology 112, 1968-1972. 24091183https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24091183","DOI":"10.1016\/j.amjcard.2013.08.028"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., Gencer, B., Hasenfuss, G., Kjeldsen, K., Lancellotti, P., Landmesser, U., Mehilli, J., Mukherjee, D., Storey, R. F. and Windecker, S. (2015) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 37, 267-315.","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"ref88","unstructured":"Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., Gencer, B., Hasenfuss, G., Kjeldsen, K., Lancellotti, P., Landmesser, U., Mehilli, J., Mukherjee, D., Storey, R. F. and Windecker, S. (2016) [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. Giornale Italiano di Cardiologia (2006) 17, 831-872."},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Russa, D. L., Pellegrino, D., Montesanto, A., Gigliotti, P., Perri, A., Russa, A. L. and Bonofiglio, R. (2019) Oxidative balance and inflammation in hemodialysis patients: biomarkers of cardiovascular risk? Oxidative Medicine and Cellular Longevity 2019, 8567275-8567275.","DOI":"10.1155\/2019\/8567275"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Russo, M. W., Sevetson, B. R. and Milbrandt, J. (1995) Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America 92, 6873-6877. 7624335https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7624335","DOI":"10.1073\/pnas.92.15.6873"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Sandoval, Y., Smith, S. W., Sexter, A., Thordsen, S. E., Bruen, C. A., Carlson, M. D., Dodd, K. W., Driver, B. E., Hu, Y., Jacoby, K., Johnson, B. K., Love, S. A., Moore, J. C., Schulz, K., Scott, N. L. and Apple, F. S. (2017) Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I. The American Journal of Medicine 130, 1431-1439.e1434.","DOI":"10.1016\/j.amjmed.2017.05.049"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Santoro, A. (2002) Cardiac effects of chronic inflammation in dialysis patients. Nephrology Dialysis Transplantation 17, 10-15.","DOI":"10.1093\/ndt\/17.suppl_8.10"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Sarkisian, L., Saaby, L., Poulsen, T. S., Gerke, O., Jangaard, N., Hosbond, S., Diederichsen, A. C. P., Thygesen, K. and Mickley, H. (2016) Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. The American Journal of Medicine 129, 446.e445-446.e421.","DOI":"10.1016\/j.amjmed.2015.11.006"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Sarnak, M. J., Amann, K., Bangalore, S., Cavalcante, J. L., Charytan, D. M., Craig, J. C., Gill, J. S., Hlatky, M. A., Jardine, A. G., Landmesser, U., Newby, L. K., Herzog, C. A., Cheung, M., Wheeler, D. C., Winkelmayer, W. C. and Marwick, T. H. (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. Journal of the American College of Cardiology 74, 1823-1838.","DOI":"10.1016\/j.jacc.2019.08.1017"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Schiffrin, E. L., Lipman, M. L. and Mann, J. F. E. (2007) Chronic kidney disease. Circulation 116, 85-97.","DOI":"10.1161\/CIRCULATIONAHA.106.678342"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Schmidt, A., Stefenelli, T., Schuster, E. and Mayer, G. (2001) Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. American Journal of Kidney Diseases 37, 56-63. 11136168https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11136168","DOI":"10.1053\/ajkd.2001.20584"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G. and Amann, K. (2000) Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrology Dialysis Transplantation 15, 218-223.","DOI":"10.1093\/ndt\/15.2.218"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Shah, A. S. V., Anand, A., Strachan, F. E., Ferry, A. V., Lee, K. K., Chapman, A. R., Sandeman, D., Stables, C. L., Adamson, P. D., Andrews, J. P. M., Anwar, M. S., Hung, J., Moss, A. J., O'Brien, R., Berry, C., Findlay, I., Walker, S., Cruickshank, A., Reid, A., Gray, A., Collinson, P. O., Apple, F. S., McAllister, D. A., Maguire, D., Fox, K. A. A., Newby, D. E., Tuck, C., Harkess, R., Parker, R. A., Keerie, C., Weir, C. J. and Mills, N. L. (2018) High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet (London, England) 392, 919-928.","DOI":"10.1016\/S0140-6736(18)31923-8"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Sharp, A. J., Patel, N., Reeves, B. C., Angelini, G. D. and Fiorentino, F. (2019) Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials. Open Heart 6, e000864-e000864.","DOI":"10.1136\/openhrt-2018-000864"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Shaw, C., Nitsch, D., Lee, J., Fogarty, D. and Sharpe, C. C. (2016) Impact of an early invasive strategy versus conservative strategy for unstable angina and non-ST elevation acute coronary syndrome in patients with chronic kidney disease: A systematic review. PloS one 11, e0153478-e0153478.","DOI":"10.1371\/journal.pone.0153478"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Sosnov, J., Lessard, D., Goldberg, R. J., Yarzebski, J. and Gore, J. M. (2006) Differential symptoms of acute myocardial infarction in patients with kidney disease: A community-wide perspective. American Journal of Kidney Diseases 47, 378-384. 16490615https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16490615","DOI":"10.1053\/j.ajkd.2005.11.017"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Stef\u00e1nsson, B. V., Brunelli, S. M., Cabrera, C., Rosenbaum, D., Anum, E., Ramakrishnan, K., Jensen, D. E. and St\u00e5lhammar, N.-O. (2014) Intradialytic hypotension and risk of cardiovascular disease. Clinical Journal of the American Society of Nephrology: CJASN 9, 2124-2132.","DOI":"10.2215\/CJN.02680314"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Subbiah, A. K., Chhabra, Y. K. and Mahajan, S. (2016) Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia 8, 56-61. 27326234https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27326234","DOI":"10.1136\/heartasia-2016-010809"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Takeda, S., Yamashita, A., Maeda, K. and Ma\u00e9da, Y. (2003) Structure of the core domain of human cardiac troponin in the Ca2+-saturated form. Nature 424, 35-41.","DOI":"10.1038\/nature01780"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Tarapan, T., Musikatavorn, K., Phairatwet, P., Takkavatakarn, K., Susantitaphong, P., Eiam-Ong, S. and Tiranathanagul, K. (2019) High sensitivity Troponin-I levels in asymptomatic hemodialysis patients. Renal Failure 41, 393-400. 31132904https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31132904","DOI":"10.1080\/0886022X.2019.1603110"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Taylor, M. J., Scuffham, P. A., McCollam, P. L. and Newby, D. E. (2007) Acute coronary syndromes in Europe: 1-year costs and outcomes. Current Medical Research and Opinion 23, 495-503.","DOI":"10.1185\/030079906X167462"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A. and White, H. D. (2018) Fourth universal definition of myocardial infarction (2018). Global Heart 13, 305-338. 30154043https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30154043","DOI":"10.1016\/j.gheart.2018.08.004"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Thygesen, K., Mair, J., Giannitsis, E., Mueller, C., Lindahl, B., Blankenberg, S., Huber, K., Plebani, M., Biasucci, L. M., Tubaro, M., Collinson, P., Venge, P., Hasin, Y., Galvani, M., Koenig, W., Hamm, C., Alpert, J. S., Katus, H. and Jaffe, A. S. (2012) How to use high-sensitivity cardiac troponins in acute cardiac care. European Heart Journal 33, 2252-2257.","DOI":"10.1093\/eurheartj\/ehs154"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Thygesen, K., Mair, J., Katus, H., Plebani, M., Venge, P., Collinson, P., Lindahl, B., Giannitsis, E., Hasin, Y., Galvani, M., Tubaro, M., Alpert, J. S., Biasucci, L. M., Koenig, W., Mueller, C., Huber, K., Hamm, C. and Jaffe, A. S. (2010) Recommendations for the use of cardiac troponin measurement in acute cardiac care. European Heart Journal 31, 2197-2204. 20685679https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20685679","DOI":"10.1093\/eurheartj\/ehq251"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Twerenbold, R., Badertscher, P., Boeddinghaus, J., Nestelberger, T., Wildi, K., Puelacher, C., Sabti, Z., Rubini Gimenez, M., Tschirky, S., du Fay de Lavallaz, J., Kozhuharov, N., Sazgary, L., Mueller, D., Breidthardt, T., Strebel, I., Flores Widmer, D., Shrestha, S., Mir\u00f3, \u00d2., Mart\u00edn-S\u00e1nchez, F. J., Morawiec, B., Parenica, J., Geigy, N., Keller, D. I., Rentsch, K., von Eckardstein, A., Osswald, S., Reichlin, T. and Mueller, C. (2018) 0\/1-Hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation 137, 436-451.","DOI":"10.1161\/CIRCULATIONAHA.117.028901"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Twerenbold, R., Wildi, K., Jaeger, C., Gimenez, M. R., Reiter, M., Reichlin, T., Walukiewicz, A., Gugala, M., Krivoshei, L., Marti, N., Moreno Weidmann, Z., Hillinger, P., Puelacher, C., Rentsch, K., Honegger, U., Schumacher, C., Zurbriggen, F., Freese, M., Stelzig, C., Campodarve, I., Bassetti, S., Osswald, S. and Mueller, C. (2015) Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 131, 2041-2050.","DOI":"10.1161\/CIRCULATIONAHA.114.014245"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Unger, E. D., Dubin, R. F., Deo, R., Daruwalla, V., Friedman, J. L., Medina, C., Beussink, L., Freed, B. H. and Shah, S. J. (2016) Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. European journal of heart failure 18, 103-112. 26635076https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635076","DOI":"10.1002\/ejhf.445"},{"key":"ref113","unstructured":"United States Food and Drug Administration (US FDA) (2017) Roche diagnostics\u2019 5th generation high-sensitivity troponin-T 2017. Available at: . https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K162895.pdf"},{"key":"ref114","unstructured":"United States Food and Drug Administration (US FDA) (2019) Architect stat high sensitivity troponin-I 2019. Available at: . https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K191595.pdf"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Valgimigli, M., Campo, G., Monti, M., Vranckx, P., Percoco, G., Tumscitz, C., Castriota, F., Colombo, F., Tebaldi, M., Fuc\u00e0, G., Kubbajeh, M. d., Cangiano, E., Minarelli, M., Scalone, A., Cavazza, C., Frangione, A., Borghesi, M., Marchesini, J., Parrinello, G. and Ferrari, R. (2012) Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting. Circulation 125, 2015-2026.","DOI":"10.1161\/CIRCULATIONAHA.111.071589"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Vlagopoulos, P. T., Tighiouart, H., Weiner, D. E., Griffith, J., Pettitt, D., Salem, D. N., Levey, A. S. and Sarnak, M. J. (2005) Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. Journal of the American Society of Nephrology 16, 3403-3410.","DOI":"10.1681\/ASN.2005030226"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Vranckx, P., Valgimigli, M., J\u00fcni, P., Hamm, C., Steg, P. G., Heg, D., van Es, G. A., McFadden, E. P., Onuma, Y., van Meijeren, C., Chichareon, P., Benit, E., M\u00f6llmann, H., Janssens, L., Ferrario, M., Moschovitis, A., Zurakowski, A., Dominici, M., Van Geuns, R. J., Huber, K., Slagboom, T., Serruys, P. W. and Windecker, S. (2018) Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet (London, England) 392, 940-949.","DOI":"10.1016\/S0140-6736(18)31858-0"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., Mahaffey, K. W., Scirica, B. M., Skene, A., Steg, P. G., Storey, R. F. and Harrington, R. A. (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine 361, 1045-1057.","DOI":"10.1056\/NEJMoa0904327"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Wallentin, L., Lindhagen, L., \u00c4rnstr\u00f6m, E., Husted, S., Janzon, M., Johnsen, S. P., Kontny, F., Kempf, T., Levin, L.-\u00c5., Lindahl, B., Stridsberg, M., St\u00e5hle, E., Venge, P., Wollert, K. C., Swahn, E. and Lagerqvist, B. (2016) Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study. The Lancet 388, 1903-1911.","DOI":"10.1016\/S0140-6736(16)31276-4"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Wallentin, L., Lindholm, D., Siegbahn, A., Wernroth, L., Becker, R. C., Cannon, C. P., Cornel, J. H., Himmelmann, A., Giannitsis, E., Harrington, R. A., Held, C., Husted, S., Katus, H. A., Mahaffey, K. W., Steg, P. G., Storey, R. F. and James, S. K. (2014) Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization. Circulation 129, 293-303.","DOI":"10.1161\/CIRCULATIONAHA.113.004420"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Wang, L. W., Fahim, M. A., Hayen, A., Mitchell, R. L., Baines, L., Lord, S., Craig, J. C. and Webster, A. C. (2011a) Cardiac testing for coronary artery disease in potential kidney transplant recipients. The Cochrane Database of Systematic Reviews CD008691. 22161434https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22161434","DOI":"10.1002\/14651858.CD008691.pub2"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Wang, L. W., Fahim, M. A., Hayen, A., Mitchell, R. L., Lord, S. W., Baines, L. A., Craig, J. C. and Webster, A. C. (2011b) Cardiac Testing for coronary artery disease in potential kidney transplant recipients: A systematic review of test accuracy studies. American Journal of Kidney Diseases 57, 476-487. 21257239https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21257239","DOI":"10.1053\/j.ajkd.2010.11.018"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Wanner, C. and Tonelli, M. (2014) KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney International 85, 1303-1309.","DOI":"10.1038\/ki.2014.31"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Wanner, C., Krane, V., M\u00e4rz, W., Olschewski, M., Asmus, H.-G., Kr\u00e4mer, W., K\u00fchn, K.-W., K\u00fctemeyer, H., Mann, J. F. E., Ruf, G. and Ritz, E. (2004) Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D Study): Demographic and baseline characteristics. Kidney and Blood Pressure Research 27, 259-266. 15316128https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15316128","DOI":"10.1159\/000080241"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Wasilewski, J., Polo\u0144ski, L., Lekston, A., Osadnik, T., Regu\u0142a, R., Bujak, K. and Kurek, A. (2015) Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center. Trials 16, 411-411.","DOI":"10.1186\/s13063-015-0934-4"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Watanabe, H., Domei, T., Morimoto, T., Natsuaki, M., Shiomi, H., Toyota, T., Ohya, M., Suwa, S., Takagi, K., Nanasato, M., Hata, Y., Yagi, M., Suematsu, N., Yokomatsu, T., Takamisawa, I., Doi, M., Noda, T., Okayama, H., Seino, Y., Tada, T., Sakamoto, H., Hibi, K., Abe, M., Kawai, K., Nakao, K., Ando, K., Tanabe, K., Ikari, Y., Hanaoka, K. I., Morino, Y., Kozuma, K., Kadota, K., Furukawa, Y., Nakagawa, Y. and Kimura, T. (2019) Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 randomized clinical trial. JAMA 321, 2414-2427. 31237644https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31237644","DOI":"10.1001\/jama.2019.8145"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Weisbord, S. D., Gallagher, M., Jneid, H., Garcia, S., Cass, A., Thwin, S.-S., Conner, T. A., Chertow, G. M., Bhatt, D. L., Shunk, K., Parikh, C. R., McFalls, E. O., Brophy, M., Ferguson, R., Wu, H., Androsenko, M., Myles, J., Kaufman, J. and Palevsky, P. M. (2018) Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. The New England Journal of Medicine 378, 603-614.","DOI":"10.1056\/NEJMoa1710933"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., J\u00fcni, P., Kappetein, A. P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.-J., Richter, D. J., Schauerte, P., Sousa Uva, M., Stefanini, G. G., Taggart, D. P., Torracca, L., Valgimigli, M., Wijns, W. and Witkowski, A. (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal 35, 2541-2619.","DOI":"10.4244\/EIJY14M09_01"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Winther, S., Svensson, M., J\u00f8rgensen, H. S., Bouchelouche, K., Gormsen, L. C., Pedersen, B. B., Holm, N. R., B\u00f8tker, H. E., Ivarsen, P. and B\u00f8ttcher, M. (2015a) Diagnostic performance of coronary CT angiography and myocardial perfusion imaging in kidney transplantation candidates. JACC: Cardiovascular Imaging 8, 553-562. 25869350https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25869350","DOI":"10.1016\/j.jcmg.2014.12.028"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Winther, S., Svensson, M., J\u00f8rgensen, H. S., Birn, H., B\u00f8tker, H. E., Ivarsen, P. and B\u00f8ttcher, M. (2015b) Repeated contrast administration is associated with low risk of postcontrast acute kidney injury and long-term complications in patients with severe chronic kidney disease. American Journal of Transplantation 16, 897-907.","DOI":"10.1111\/ajt.13545"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Yerkey, M. W., Kernis, S. J., Franklin, B. A., Sandberg, K. R. and McCullough, P. A. (2004) Renal dysfunction and acceleration of coronary disease. Heart (British Cardiac Society) 90, 961-966.","DOI":"10.1136\/hrt.2003.015503"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/21\/2\/10.31083\/j.rcm.2020.02.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:52:43Z","timestamp":1747644763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/21\/2\/10.31083\/j.rcm.2020.02.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["2153-8174-21-2-191"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm.2020.02.17","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"article-number":"191"}}